142 related articles for article (PubMed ID: 31444000)
1. Discovery of a novel chalcone derivative inhibiting CFTR chloride channel via AMPK activation and its anti-diarrheal application.
Yibcharoenporn C; Chusuth P; Jakakul C; Rungrotmongkol T; Chavasiri W; Muanprasat C
J Pharmacol Sci; 2019 Jul; 140(3):273-283. PubMed ID: 31444000
[TBL] [Abstract][Full Text] [Related]
2. Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease.
Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 22186622
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CFTR-mediated intestinal chloride secretion by a fungus-derived arthropsolide A: Mechanism of action and anti-diarrheal efficacy.
Akrimajirachoote N; Satitsri S; Sommart U; Rukachaisirikul V; Muanprasat C
Eur J Pharmacol; 2020 Oct; 885():173393. PubMed ID: 32712094
[TBL] [Abstract][Full Text] [Related]
4. Activation of AMP-activated protein kinase by a plant-derived dihydroisosteviol in human intestinal epithelial cell.
Muanprasat C; Sirianant L; Sawasvirojwong S; Homvisasevongsa S; Suksamrarn A; Chatsudthipong V
Biol Pharm Bull; 2013; 36(4):522-8. PubMed ID: 23343619
[TBL] [Abstract][Full Text] [Related]
5. A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease.
Veeraphan P; Chavasiri W; Muanprasat C; Chatsudthipong V; Yuajit C
Clin Exp Nephrol; 2021 Sep; 25(9):944-952. PubMed ID: 34057612
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanisms underlying the inhibitory effect of flufenamic acid on chloride secretion in human intestinal epithelial cells.
Pongkorpsakol P; Yimnual C; Chatsudthipong V; Rukachaisirikul V; Muanprasat C
J Pharmacol Sci; 2017 Jun; 134(2):93-100. PubMed ID: 28651800
[TBL] [Abstract][Full Text] [Related]
7. A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheas.
Muangnil P; Satitsri S; Tadpetch K; Saparpakorn P; Chatsudthipong V; Hannongbua S; Rukachaisirikul V; Muanprasat C
Biochem Pharmacol; 2018 Apr; 150():293-304. PubMed ID: 29475061
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cAMP-activated intestinal chloride secretion by diclofenac: cellular mechanism and potential application in cholera.
Pongkorpsakol P; Pathomthongtaweechai N; Srimanote P; Soodvilai S; Chatsudthipong V; Muanprasat C
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3119. PubMed ID: 25188334
[TBL] [Abstract][Full Text] [Related]
9. Novel Action of the Chalcone Isoliquiritigenin as a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor: Potential Therapy for Cholera and Polycystic Kidney Disease.
Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 32092841
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of intestinal chloride secretion by piperine as a cellular basis for the anti-secretory effect of black peppers.
Pongkorpsakol P; Wongkrasant P; Kumpun S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2015 Oct; 100():271-80. PubMed ID: 26297981
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea.
Duan T; Cil O; Tse CM; Sarker R; Lin R; Donowitz M; Verkman AS
FASEB J; 2019 Oct; 33(10):10924-10934. PubMed ID: 31268738
[TBL] [Abstract][Full Text] [Related]
12. A plant-derived hydrolysable tannin inhibits CFTR chloride channel: a potential treatment of diarrhea.
Wongsamitkul N; Sirianant L; Muanprasat C; Chatsudthipong V
Pharm Res; 2010 Mar; 27(3):490-7. PubMed ID: 20225391
[TBL] [Abstract][Full Text] [Related]
13. Activation of constitutive androstane receptor inhibits intestinal CFTR-mediated chloride transport.
Kittayaruksakul S; Sawasvirojwong S; Noitem R; Pongkorpsakol P; Muanprasat C; Chatsudthipong V
Biomed Pharmacother; 2019 Mar; 111():1249-1259. PubMed ID: 30841439
[TBL] [Abstract][Full Text] [Related]
14. β-eudesmol but not atractylodin exerts an inhibitory effect on CFTR-mediated chloride transport in human intestinal epithelial cells.
Tharabenjasin P; Ferraris RP; Choowongkomon K; Pongkorpsakol P; Worakajit N; Sawasvirojwong S; Pabalan N; Na-Bangchang K; Muanprasat C
Biomed Pharmacother; 2021 Oct; 142():112030. PubMed ID: 34426253
[TBL] [Abstract][Full Text] [Related]
15. Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation.
Pongkorpsakol P; Satitsri S; Wongkrasant P; Chittavanich P; Kittayaruksakul S; Srimanote P; Chatsudthipong V; Muanprasat C
Eur J Pharmacol; 2017 Mar; 798():94-104. PubMed ID: 28119077
[TBL] [Abstract][Full Text] [Related]
16. Activation of AMPK inhibits cholera toxin stimulated chloride secretion in human and murine intestine.
Rogers AC; Huetter L; Hoekstra N; Collins D; Collaco A; Baird AW; Winter DC; Ameen N; Geibel JP; Kopic S
PLoS One; 2013; 8(7):e69050. PubMed ID: 23935921
[TBL] [Abstract][Full Text] [Related]
17. Natural statin derivatives as potential therapy to reduce intestinal fluid loss in cholera.
Noitem R; Pongkorpsakol P; Changsen C; Sukpondma Y; Tansakul C; Rukachaisirikul V; Muanprasat C
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010989. PubMed ID: 36490300
[TBL] [Abstract][Full Text] [Related]
18. Genistein and tyrphostin 47 stimulate CFTR-mediated Cl- secretion in T84 cell monolayers.
Sears CL; Firoozmand F; Mellander A; Chambers FG; Eromar IG; Bot AG; Scholte B; De Jonge HR; Donowitz M
Am J Physiol; 1995 Dec; 269(6 Pt 1):G874-82. PubMed ID: 8572219
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyxanthone as an inhibitor of cAMP-activated apical chloride channel in human intestinal epithelial cell.
Luerang W; Khammee T; Kumpum W; Suksamrarn S; Chatsudthipong V; Muanprasat C
Life Sci; 2012 Jun; 90(25-26):988-94. PubMed ID: 22634581
[TBL] [Abstract][Full Text] [Related]
20. Pranlukast inhibits renal epithelial cyst progression via activation of AMP-activated protein kinase.
Pathomthongtaweechai N; Soodvilai S; Chatsudthipong V; Muanprasat C
Eur J Pharmacol; 2014 Feb; 724():67-76. PubMed ID: 24360935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
